COVID and flu surge could strain hospitals as JN.1 variant grows, CDC warns
"COVID-19 hospitalizations are rising quickly," the CDC said, and the new variant JN.1 is making up an increasing share of cases.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
"COVID-19 hospitalizations are rising quickly," the CDC said, and the new variant JN.1 is making up an increasing share of cases.
From 2003 to 2021, 1,262 unintentional gun deaths of children were reported in the U.S.
More than 1 in 4 women who have had sex say they've used emergency contraception. The survey also found fewer teens are sexually active.
Health officials say the "urgent crisis" in antibiotic resistant bacteria must be addressed, even during a war.
Cases of other respiratory illnesses, including flu and RSV, are also on the rise.
A federal court had ordered the company to pause making and selling its products.
A highly-mutated descendant called JN.1 could be to blame.
The illegal Neptune's Fix brand supplements claim to contain tianeptine, known as "gas station heroin."
One family said their son had eaten the pouches up to six times a day.
The next round of free COVID test orders will ship starting the week of Nov. 27.
Two companies behind the supplements brand Balance of Nature had flouted years of warnings, the FDA said.
The FDA's "leading hypothesis" on the lead that has forced recalls of some applesauce products blames cinnamon from Ecuador.
Measles outbreaks worldwide climbed 68% from 2021.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.